Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8236101 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 10 Pages |
Abstract
AT/RT-CD133+ exhibit CSC properties and are refractory to IR treatment. Our results suggest that RV treatment plays crucial roles in antiproliferative, proapoptotic, and radiosensitizing effects on treated-CD133+/-; RV may therefore improve the clinical treatment of AT/RT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Chung-Lan M.D., Ph.D., Pin-I M.D., Ping-Hsing M.S., Ming-Long B.S., Jeng-Fan Ph.D., Yi-Yen M.D., Yann-Jang M.D., Ph.D., Yi-Wei M.D., Shih-Hwa M.D., Ph.D.,